Newsletter

🦾Multimodal breast imaging AI could cut unnecessary biopsies as MHRA pushes smarter regulation

Breast imaging AI could reduce unnecessary biopsies, while MHRA pushes smarter regulation for healthcare AI adoption.

Clinician-written evidence makes clinical LLMs safer as prostate AI moves into care

Clinical LLMs get safer with clinician-written evidence, while Tempus brings AI-powered prostate digital pathology into metastatic cancer care.

AI aided CT Reporting Gets More Transparent as Prostate MRI AI Clears Regulators

Traceable CT agents, FDA-cleared prostate MRI AI and rare-disease gene models show how clinical AI is moving into real workflows.

NHS opens £900m AI framework as Google researchers test conversational AI with real patients

NHS SBS launches a £900m AI framework as Google researchers test AMIE, a conversational diagnostic AI, in real urgent care.

AI Drug Design’s $2.1B Moment, Plus Harvard’s Compass Model

AI drug discovery, cancer prediction, and smarter hospitals.

AI healthcare update: Isomorphic Labs raises $2.1B for AI drug discovery, Harvard’s Compass predicts immunotherapy response, and hospital AI tools advance.

LungIMPACT RCT shows AI chest X-ray prioritisation adds no speed to lung cancer diagnosis

LungImpact trial results, FDA regulations, and the latest in medical imaging infrastructure advances.